Health information; creating the Oklahoma Health Care Transparency Initiative Act of 2026; requiring and authorizing submission of certain data; providing data privacy and security protections; providing penalties; establishing Health Care Cost Transparency Board.
HB3647 creates the Oklahoma Health Care Transparency Initiative Act of 2026, a statewide health care data collection and transparency framework centered on an all-payer claims database. The bill requires certain health insurers, health benefit plans, third-party administrators, pharmacy benefit managers, risk-based provider organizations, and some public programs to submit claims data, unique identifiers, geographic and demographic information, and provider files to the state-designated health information exchange entity beginning in 2027, with implementation to begin by July 1, 2027. It also directs the Office of the State Coordinator for Health Information Exchange to oversee the initiative and enforce compliance.
The bill expands the role of the state-designated entity for health information exchange and creates a new Health Care Cost Transparency Board within the Insurance Department. That board would analyze statewide spending, utilization, cost growth, and primary care investment, and would issue annual reports and policy recommendations to the Governor and Legislature. The measure also requires coordination with the State Department of Health to incorporate certain public health and vital statistics data, including hospital discharge and emergency department records for the uninsured, birth and death records, and disease registry data.
HB3647 would amend Title 63 and Title 36, and also modify the Oklahoma Open Records Act, to make health care claims and related data submitted to the initiative confidential and exempt from public records disclosure. It establishes detailed privacy, security, and HIPAA-compliance requirements, prohibits public disclosure of direct personal identifiers, and preserves trade secret protections. The bill also authorizes fines of up to $1,000 per day for noncompliance, with collected proceeds used to support administration of the initiative. In practical terms, the measure would impose new reporting obligations on insurers and other submitting entities while giving state agencies a broader data set for health care cost analysis and policy development.
The bill appears to have generally favorable momentum in committee and on the floor, with unanimous or near-unanimous committee approvals early in the process and a strong House third-reading vote of 61-32. The Senate Health and Human Services Committee also advanced the committee substitute by a 10-2 vote. Overall, the discussion and voting history suggest broad support for the goal of improving transparency in health care costs and utilization, while still reflecting some reservations among a minority of lawmakers.
The main points of contention likely center on mandatory data submission, the scope of entities covered, and privacy/confidentiality concerns. Insurers, third-party administrators, pharmacy benefit managers, and other submitting entities must provide detailed claims and demographic data, which may raise concerns about administrative burden, data security, and the handling of proprietary information. The bill attempts to address those concerns through HIPAA-based protections, exemptions for some providers, confidentiality rules, and limits on disclosure of direct identifiers and trade secrets, but the 32 House no votes and 2 Senate committee no votes indicate that some lawmakers remained uneasy about the breadth of the reporting regime and the state’s use of sensitive health data.